Clik here to view.
Shionogi Reports Positive Results from Cefiderocol Phase III Study in Adults...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced results from APEKS-NP, an international, double-blind, randomized Phase III clinical trial...
View ArticleClik here to view.
TCT 2019におけるPROTECT IIIの結果発表：ImpellaによるプロテクテッドPCIに転帰改善が伴うことを臨床データが証明
サンフランシスコ （ビジネスワイヤ） — アビオメッド（NASDAQ: ABMD）は、PROTECT III試験の結果を発表します。PROTECT IIIは、高リスクPCI患者でImpella 2.5およびImpella CPに対する市販後承認（PMA）を取得すべく進行中の前向き単群のFDA承認後試験で、PROTECT IIランダム化対照試験（RCT）に続くものです。...
View ArticleClik here to view.
NMPA Approves IND Application for CT103A, a Fully-human BCMA CAR-T for the...
NANJING, China IASO Biotherapeutics (IASO BIO), a clinical stage biotechnology company advancing the development of innovative therapies for cancer, and Innovent Biologics, Inc. (Innovent)...
View ArticleClik here to view.
Agilent Receives Approval for First PD-L1 Companion Diagnostic in China
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that the National Medical Products Administration (NMPA, formerly the China Food and Drug Administration) has approved its...
View ArticleClik here to view.
Ecolab Acquires Gallay Medical & Scientific
ST. PAUL, Minn. Ecolab Inc., the global leader in water, hygiene and energy technologies and services that protect people and vital resources, has acquired Gallay Medical & Scientific, a leading...
View ArticleClik here to view.
富士フイルム：フィリップ・コトラー教授主宰2019ワールドマーケティングサミットにグローバルパートナーとして協賛
東京 （ビジネスワイヤ） — 富士フイルムホールディングス株式会社（社長：助野 健児）(東証:4901)は、2019ワールドマーケティングサミットにグローバルパートナーとして協賛いたします。 ワールドマーケティングサミットは、「近代マーケティングの父」であるノースウェスタン大学...
View ArticleClik here to view.
Fujifilm to Sponsor the World Marketing Summit 2019, Organized by Professor...
TOKYO FUJIFILM Holdings Corporation (President: Kenji Sukeno)(TOKYO:4901) is pleased to announce that it will sponsor the World Marketing Summit 2019 as a global partner. The World Marketing Summit...
View ArticleClik here to view.
Fuzionaire Diagnostics Partners with Japan Medical Isotope Technology...
PASADENA, Calif. Fuzionaire Diagnostics (“Fuzionaire Dx”), in partnership with Tokyo-based radiopharmaceutical company Japan Medical Isotope Technology Development K.K. (“JAMIT”), today announced...
View ArticleClik here to view.
NantHealth®, GE Healthcare, AirStrip and iProcedures Join Forces to Present...
BANGKOK & CULVER CITY, Calif. NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will be presenting with GE Healthcare,...
View ArticleClik here to view.
MPEG LA、査読論文のNucleic Acid Therapeutics誌への掲載を発表
デンバー （ビジネスワイヤ） — 技術ライセンシングの世界的リーダー企業MPEG LAは本日、Nucleic Acid Therapeutics誌の2019年10月号に、MPEG LA専有のリガンド指向型多重ペイロード・オリゴヌクレオチド送達プラットフォームIncrescent Therapeutics™に関する査読論文が掲載されたと発表しました。 MPEG...
View ArticleClik here to view.
Clik here to view.
Abiomed Announces 1,000th Patient Treated with Impella in Japan
TOKYO Abiomed (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, announces the 1,000th patient has been treated with the Impella heart pump in Japan. The Impella 2.5 and...
View ArticleClik here to view.
GRAIL Announces Positive Validation Data for Its Multi-Cancer Early Detection...
MENLO PARK, Calif. GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced new data validating the performance of its investigational multi-cancer early detection...
View ArticleClik here to view.
CORRECTING and REPLACING GRAIL Announces Positive Validation Data for Its...
MENLO PARK, Calif. Ninth paragraph, first sentence of the release should read: In the group of more than 20 cancer types, the overall detection rate at 99.3 percent specificity was 55 percent...
View ArticleClik here to view.
Mitsubishi Electric Unveils “EMIRAI S” Concept Cabin
TOKYO Mitsubishi Electric Corporation (TOKYO: 6503) today unveiled its EMIRAI S concept car equipped with cutting-edge technologies, such as an innovative human-machine interface and...
View ArticleClik here to view.
Clik here to view.
Nuwiq®产品特性概述更新版纳入每周两次给药个体化预防性治疗有效保护出血的数据
瑞士拉亨 (美国商业资讯)–Octapharma今天宣布，欧洲药品管理局已核准Nuwiq®产品特性概述(SmPC)更新版纳入血友病A患者个体化预防性治疗的信息。此次更新版SmPC的网址是https://www.ema.europa.eu/en/medicines/human/EPAR/nuwiq...
View ArticleClik here to view.
Gilead Sciences Submits New Drug Application for Filgotinib for the Treatment...
FOSTER CITY, Calif. Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the New Drug Application (NDA) for filgotinib, an investigational, oral, selective JAK1 inhibitor for the treatment of...
View ArticleClik here to view.
Samyang Biopharm USA Expands and Strengthens its US Operations and Makes...
CAMBRIDGE, Mass. Samyang Biopharm USA, (us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Pharmaceuticals Corp. (https://samyangbiopharm.com/eng), today announced that it is...
View ArticleClik here to view.
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4...
NORTH BRUNSWICK, N.J. Adlai Nortye Ltd. (“Adlai Nortye” or “the Company”), a global clinical-stage biopharmaceutical company dedicated to discovery, development and commercialization of new and...
View Article